BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:05 PM
 | 
Sep 17, 2008
 |  BC Extra  |  Company News

Merck ends I-vation deal

Merck (NYSE:MRK) ended a 2007 deal with SurModics (NASDAQ:SRDX) to develop SurModics' I-vation sustained delivery system for use with triamcinolone acetonide (TA) to treat retinal disease. The termination triggers a $9 million payment to SurModics, bringing the...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >